EUVIMEDEUVIMED entdecken
Crossref

1812-P: Lupin Flour Improves Glucose Metabolism in an mdx Mouse Model of Duchenne Muscular Dystrophy

ROBERTO CODELLA, FERNANDA VACANTE, PAMELA SENESI, LIVIO LUZI, ILEANA M. TERRUZZI

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-1812-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ROBERTO CODELLA und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Insulin resistance is increasingly recognized as a metabolic feature of chronic muscle disorders, including Duchenne muscular dystrophy. This study evaluated the beneficial effects of chronic lupin flour (LF) supplementation, a protein-rich legume with insulin-mimetic properties, on glucose metabolism in an mdx mouse model of DMD.

Methods

Twelve-week-old male wild-type (C57BL/6T, n=20) and mdx (n=20) mice were assigned to four groups (WT, WT+LF, mdx, mdx+LF) and fed a standard diet with or without 2% (w/w) LF 8 weeks. Blood samples collected at baseline and study end were used to assess glycemia, insulin levels, and HOMA index as markers of insulin resistance.

Results

LF supplementation significantly reduced final glycemia in both WT and mdx mice (p < 0.05-0.001), with a parallel reduction in HOMA index, indicating improved insulin sensitivity. In WT mice, LF lowered plasma glucose and insulin levels compared with untreated controls, consistent with insulin-mimetic activity. Untreated mdx mice exhibited insulin resistance, as reflected by higher baseline glucose, insulin, and HOMA values versus WT controls. LF partially normalized these metabolic alterations in mdx mice. Two-way ANOVA revealed significant main effects of treatment and time (p < 0.001), with no interaction, indicating a consistent metabolic benefit over time. LF-treated mdx mice also showed partial restoration of growth trajectories compared with untreated mdx animals.

Conclusion

These findings provide evidence for insulin resistance as a metabolic feature of mdx mice and support lupin flour supplementation as a nutritional strategy to improve glucose metabolism and insulin sensitivity in conditions characterized by muscle-related metabolic dysfunction. Disclosure R. Codella: None. F. Vacante: None. P. Senesi: None. L. Luzi: None. I.M. Terruzzi: None.

Zitieren

APA

CODELLA, R., VACANTE, F., SENESI, P., LUZI, L., & TERRUZZI, I. M. (2026). 1812-P: Lupin Flour Improves Glucose Metabolism in an mdx Mouse Model of Duchenne Muscular Dystrophy. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1812-p

Vancouver

CODELLA R, VACANTE F, SENESI P, LUZI L, TERRUZZI IM. 1812-P: Lupin Flour Improves Glucose Metabolism in an mdx Mouse Model of Duchenne Muscular Dystrophy. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1812-p

BibTeX
@article{CODELLA2026,
  author = {CODELLA, ROBERTO and VACANTE, FERNANDA and SENESI, PAMELA and LUZI, LIVIO and TERRUZZI, ILEANA M.},
  title = {1812-P: Lupin Flour Improves Glucose Metabolism in an mdx Mouse Model of Duchenne Muscular Dystrophy},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-1812-p}
}
Kostenlos starten →